ImmunityBio, Inc. (IBRX)
Market Closed
17 Jul, 20:00
$
7. 68
+0.23
+3.0872%
$
8.61B Market Cap
- P/E Ratio
- Div Yield
9.02M Volume
-0.93 Eps
$ 7.45
Previous Close 
Want to track IBRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
ImmunityBio, Inc. (IBRX) Statistics
Valuation metrics
Market Cap 8.61B
Enterprise value 8.96B
Trailing P/E (ttm) -9
Forward P/E -403.5
PEG ratio 0.07
Price/Sales (ttm) 57.06
Price/Book (mrq) -9.06
Enterprise Value/Revenue 63.58
Enterprise Value/EBITDA -12.34
Overview
Shares outstanding 1.01B
Float 377.71M
Shares short 135.54M
% Held by insiders 0.64%
% Held by institutions 0.17%
Average volume (10 days) 8.35M
Average volume (90 days) 13.24M
Price summary
52-Week low 1.95
52-Week high 12.43
Beta 0.06
50-Day moving average 7.78
200-Day moving average 7.11
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -6.06%
Operating margin -1.85%
Operational effectiveness
Return on assets -1.32%
Return on equity 1.39%
Income Statement
Revenue (ttm) 113.29M
Revenue per share (ttm) 0.14
Quarterly revenue growth (yoy) 4.07%
Gross profit (ttm) 112.53M
EBITDA -240.6M
Net income to common (ttm) -351.4M
Diluted EPS (ttm) -0.83
Quarterly earnings growth (yoy) 4.07%
Balance Sheet
Total cash (mrq) 242.82M
Total cash per share (mrq) 0.37
Total debt (mrq) 844.72M
Total Debt/Equity (mrq) -1.29
Current ratio (mrq) 6.67%
Book value per share (mrq) -0.85
Cash Flow
Cash flow statement -304.94M
Levered free cash flow (LFCF) -213.36M
